Please provide your email address to receive an email when new articles are posted on . With the rise of hospitalists, in an inpatient setting, this process is often handled and overseen by hospital ...
A clinic visit, hospital admission, or transition in care often begins with medication reconciliation. Developed to provide safer, more coordinated, and better-quality care, medication reconciliation ...
The Agency for Healthcare Research and Quality provides a free, downloadable medications at transitions and clinical handoffs toolkit for medication reconciliation. Medication reconciliation is a ...
Background: Hospital discharge is an interface of care when patients are at a high risk of medication discrepancies as they transition from hospital to home. These discrepancies are important, as they ...
Researchers studied 851 adults hospitalized with acute coronary syndromes or acute decompensated heart failure at two tertiary care academic hospitals. A randomized group of patients received ...
Jeannie Pezone, administrator at West Park Surgery Center in Pinellas Park, Fla., explains the process the surgery center uses to ensure medication reconciliation is achieved according to standards ...
Objective Geriatric patients often face issues related to polypharmacy and adverse drug events. Re-evaluating prescribed medications and considering deprescribing is critical. Medication discrepancies ...
A new study from researchers from Brigham and Women's Hospital, a founding member of the Mass General Brigham healthcare system, has shed new light on the best strategies hospitals can use for ...
Disparities in National Cancer Institute and Nonprofit Organization Funding Disproportionately Affect Cancers With Higher Incidence Among Black Patients and Higher Mortality Rates This study aims to ...
"Proper medication reconciliation involves verifying a patient's medication history, clarifying that information when necessary, and making sure any further treatment fits with the patient's past and ...
Phase Ib Study of BI 836880 (VEGF/Ang2 nanobody) in Combination With Ezabenlimab (anti–PD-1 antibody) in Patients With Advanced or Metastatic Solid Tumors From December 2022 to January 2025, one MRT ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results